Published in
Elsevier, EBioMedicine, (75), p. 103801, 2022
DOI: 10.1016/j.ebiom.2021.103801
Links
Tools
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
Journal article published in 2022 by
Aleix Prat 
,
Valentina Guarneri,
Tomás Pascual ,
Fara Brasó-Maristany,
Esther Sanfeliu,
Laia Paré,
Francesco Schettini,
Débora Martínez,
Pedro Jares,
Gaia Griguolo,
Maria Vittoria Dieci,
Javier Cortés,
Antonio Llombart-Cussac,
Benedetta Conte,
Mercedes Marín-Aguilera
and other authors.
,
Valentina Guarneri,
Tomás Pascual ,
Fara Brasó-Maristany,
Esther Sanfeliu,
Laia Paré,
Francesco Schettini,
Débora Martínez,
Pedro Jares,
Gaia Griguolo,
Maria Vittoria Dieci,
Javier Cortés,
Antonio Llombart-Cussac,
Benedetta Conte,
Mercedes Marín-Aguilera
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 